Automated nucleic acid extraction
Benchtop instruments that automate DNA/RNA purification from biological samples — spin-column robots, magnetic-bead purifiers and liquid-biopsy sample-prep platforms — replacing manual extraction kits with standardized, walk-away processing for molecular diagnostics, sequencing library prep and biopharma QC.
1 · What it gives
Automated nucleic acid extraction instruments purify DNA or RNA from raw biological samples — blood, tissue, cells, swabs or plasma — replacing the manual pipetting sequence of a spin-column or bead-based extraction kit with a walk-away instrument run. Two purification chemistries dominate: spin-column systems drive the sample through a silica-membrane column using centrifugal or vacuum force at each wash and elution step, while magnetic-bead systems bind nucleic acids to paramagnetic beads and move a magnetic probe head between wells to wash and elute, a format that scales more readily to high- throughput 96-well processing. A newer generation of liquid-biopsy sample-prep platforms extends automated extraction to circulating cell-free DNA and RNA from plasma, a lower- input, higher-sensitivity application driven by oncology and non-invasive prenatal testing demand. The instrument sits upstream of nearly every molecular workflow — PCR/qPCR diagnostics, next-generation sequencing library preparation, and biopharma genomic QC all depend on consistent, high-purity nucleic acid input, making extraction automation a foundational rather than a specialized piece of lab infrastructure.
The key directions of automated nucleic acid extraction are:
- Magnetic-bead purification systems (Magnetic Bead Extraction): paramagnetic bead-based binding, washing and elution scales more readily to 96-well high-throughput processing than spin-column methods.
- Spin-column automation (Spin-Column Robots): robotic systems that automate the centrifugal or vacuum-driven silica-membrane spin-column workflow familiar from manual extraction kits, for lower-throughput or single-sample processing.
- Liquid-biopsy sample-prep automation (Liquid Biopsy Prep): platforms optimized for low-input, high-sensitivity extraction of circulating cell-free DNA/RNA from plasma, serving oncology and prenatal-testing applications.
- High-throughput plate-based extraction (HT Plate Extraction): 96- or 384-well automated extraction integrated into a broader liquid-handling deck for genomics or diagnostics labs processing large sample batches.
Sectoral value chain#
[Raw sample: blood/tissue/plasma/swab] ──> [Lysis] ──> [Binding/wash cycles] ──> [Elution: purified DNA/RNA]
│
(QC: yield/purity check)
│
▼
[Downstream assay: PCR/NGS/QC] <─── [Software: run tracking, sample-ID logging]
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Sample lysis | The raw sample is chemically or mechanically lysed to release nucleic acids from cells or viral particles. | In: raw blood/tissue/plasma/swab sample, lysis buffer. Out: lysate ready for binding. |
| Binding | Nucleic acids bind to a silica spin-column membrane or paramagnetic beads, typically under chaotropic-salt conditions. | In: lysate, binding reagent/beads. Out: bound nucleic acid on column/beads. |
| Wash cycles | Automated wash steps remove proteins, salts and other contaminants while nucleic acid remains bound. | In: bound nucleic acid, wash buffers. Out: washed, purified-bound nucleic acid. |
| Elution | Nucleic acid is released from the column or beads into a defined elution buffer volume. | In: washed bound nucleic acid, elution buffer. Out: purified DNA/RNA in solution. |
| Software: run tracking | Instrument software logs sample IDs, run parameters and yield/purity QC metrics for each extraction. | In: run and sample metadata. Out: traceable extraction record, QC report. |
| Downstream handoff | Purified nucleic acid is quantified and moved to PCR, sequencing library prep, or biopharma genomic QC. | In: purified DNA/RNA. Out: assay-ready input for downstream molecular workflows. |
Cross-cutting technologies of the sector:
- Digital connectivity and audit trails: newer instrument generations (e.g., “Connect”-branded platforms) add networked run tracking and 21 CFR Part 11-compliant audit trails for regulated environments.
- Pathogen-specific extraction chemistries: kit chemistries increasingly target specific sample-to-pathogen combinations (e.g., low-titer viral RNA from plasma) rather than one generic protocol for all sample types.
- Integration with upstream liquid-biopsy sample handling: extraction platforms are increasingly paired with dedicated upstream sample-prep systems to handle the low-input, high-sensitivity demands of circulating cell-free nucleic acids.
2 · What it replaces 2 · matched by industry
| D2E4 | Crop disease forecasting models, spore traps, pheromone and smart pest traps and field diagnostics — spray when risk is real instead of calendar-based fungicide and insecticide programmes Replaces: Fixed-interval ("calendar") protective fungicide sprays and routine insecticide applications regardless of pest pressure | EAC |
| D2E– | On-farm culture, PCR panels, rapid tests and veterinary laboratory services for livestock and aquaculture — treat what is diagnosed instead of blanket and prophylactic antibiotic treatment Replaces: Blanket treatment of every clinical mastitis case, group metaphylaxis on suspicion, prophylactic antibiotics in hatcheries and ponds, … | DIAG |
3 · How to implement 6 steps
- 1Sample lysisThe raw sample — blood, tissue, plasma or a swab — is chemically or mechanically lysed with a lysis buffer to release nucleic acids from cells or viral particles into solution.
- 2BindingLysate is mixed with a binding reagent so that nucleic acids adsorb to a silica spin-column membrane or paramagnetic beads, typically under chaotropic-salt conditions that favor nucleic-acid binding over protein contaminants.
- 3Wash cyclesAutomated wash steps pass buffer through the column or move the magnetic bead pellet through wash solutions, removing residual protein, salt and other contaminants while nucleic acid remains bound.
- 4ElutionPurified nucleic acid is released from the column or beads into a defined volume of elution buffer, yielding DNA or RNA ready for quantification.
- 5Yield and purity QCTesting & analyticsInstrument or downstream software logs extraction yield and purity metrics (such as A260/A280 ratio) for each sample, generating a traceable QC record.Who can do this step matched automatically✓ GMP industrial scale“ProBio: A global CRDMO (contract research, development, and manufacturing organization) providing end-to-end solutions for biologics and cell and gene therapy (CGT).”Esco Aster Singapore5,000 L industrial scale“Esco Aster (Singapore) is a cGMP contract research, development and manufacturing organization (CRDMO/CDMO) and bioinnovation venture accelerator that helps clients and …”
- 6Downstream handoffPurification & downstreamTesting & analytics
Purified, quantified nucleic acid moves to PCR/qPCR diagnostics, sequencing library preparation, or biopharma genomic QC, with a 21 CFR Part 11-compliant audit trail supporting regulated downstream use.
Who can do this step matched automatically✓ GMP 500 m3“Development of robust, scalable fermentation and downstream processing (production and recovery/yield optimization).”HLB Genex (ex-GenoFocus) South Koreaindustrial scale“With fungal and bacterial secretion systems, we custom produce the evolved enzyme products in large-scale fermentation and downstream processes.”✓ GMP industrial scale“testing, including mass spectrometry and analytical high performance liquid chromatography”
4 · Who delivers
Matched suppliers (matched automatically)
| Thermo Fisher Scientific | United States | Producer | active |
| Caladan Bio | United States | Producer | active |
| Daesang | South Korea | Producer | active |
| Tsingke Biotechnology | China | Producer | active |
| Ginkgo Bioworks | United States | Producer | active |
| Aum Enzymes / Infinita Biotech | India | Producer | active |
| Alvinesa Natural Ingredients | B Corp | Spain | Producer | active |
In the services and supply catalogue 2 · paid service
Laboratory & analytical instruments · Spare parts, service & calibration
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Qiagen | 🇩🇪 Germany | QIAcube Connect | Spin-column automation; 4,000+ instrument placements | Commercial, public (QGEN) |
| Thermo Fisher Scientific | 🇺🇸 USA | KingFisher Presto, KingFisher PlasmidPro | Magnetic-bead purification; plasmid-specific configuration | Commercial, public (NYSE:TMO) |
| Promega | 🇺🇸 USA | Maxwell, Maxprep Liquid Handler | Multi-analyte magnetic-bead extraction; forensic-validated automation | Commercial |
| Roche | 🇨🇭 Switzerland | MagNA Pure 96 | Magnetic-bead DNA/viral nucleic acid purification | Commercial, public (ROG.SW) |
| Hamilton Company | 🇺🇸 USA | NIMBUS (Microlab STAR platform) | Liquid-handling-based extraction; liquid-biopsy sample-prep integration | Commercial |
5 · Rules & route to market
declaration registered within 3 working days (testing extra); certification longer
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
The US hosts three of the category’s largest instrument makers, spanning general-purpose molecular diagnostics extraction through emerging liquid-biopsy sample-prep automation.
magnetic-bead high-throughput extraction, versatile benchtop sample prep, liquid-biopsy automation partnerships#
- Thermo Fisher Scientific: the KingFisher Presto is a versatile benchtop sample- preparation instrument for nucleic acid purification, and the KingFisher PlasmidPro extends the platform to automated plasmid purification for a distinct downstream application.
- Promega: the Maxwell (including the MDx 16) provides automated nucleic acid purification methods for multiple analyte types via sample lysis and magnetic-bead binding, and the Maxprep Liquid Handler has been developmentally validated for automated sample processing in human-identification (forensic) applications.
- Hamilton Company: the NIMBUS platform, built on the Microlab STAR liquid-handling architecture, is deployed in published automated extraction methods and in a 2026 collaboration with nRichDX advancing automated liquid-biopsy sample-prep capability.
European Union
Germany and Switzerland both host category-defining instrument makers, with Qiagen’s placement scale in particular signaling the depth of the automated-extraction market.
spin-column automation leadership, high-volume placement scale, magnetic-bead diagnostic platforms#
- Qiagen (Germany): the QIAcube Connect marked its 4,000th placement in the current cycle, reaffirming leadership in automated sample processing with spin-column technology processing up to 12 samples per run and digital connectivity for lab efficiency.
- Roche (Switzerland): the MagNA Pure 96 platform provides magnetic-bead-based DNA and viral nucleic acid purification, including small-volume kit configurations for diagnostic and research applications.
China
No China-headquartered automated nucleic acid extraction vendor cleared this screening round with confirmed, on-domain evidence; demand is driven by China’s expanding molecular-diagnostics and genomics testing base, currently served largely through the global vendors’ regional distribution and applications-support networks.
import-dependent instrumentation, domestic molecular-diagnostics demand, distributor-served market#
- Global vendor distribution: Qiagen, Promega, Thermo Fisher, Roche and Hamilton each maintain China sales and applications-support organizations serving domestic molecular- diagnostics and genomics laboratories.
- Domestic molecular-diagnostics build-out: China’s growing PCR-testing and genomics laboratory base is the main demand driver for automated extraction, without a confirmed domestic instrument originator identified in this screen.
- Screening note: two candidate China-headquartered instrument makers were probed and neither returned confirming, on-domain evidence this round — not asserted as absent, only as unconfirmed.
6 · Money: tenders & grants
| Grant | Automated Scientific Discovery – Food (RAISE pilot) European Commission · EU | Feb 2, 2027 71 days |
| Grant | Development of cell-free protein synthesis platforms for discovery and/or production of biologicals European Commission · EU | Apr 13, 2027 141 days |
| Grant | Replacing hazardous substances in biocidal products European Commission · EU | Sep 22, 2027 303 days |
| Grant | Research and Development (RAD) Directed Energy (RD) University Assistance Instruments Air Force -- Research Lab · United States | Jul 18, 2029 968 days |
| Grant | Textile circularity through advanced processing and manufacturing technologies and system approaches (IA) … European Commission · EU | Feb 2, 2027 71 days |
7 · Tech stack & innovations
The stack layers lysis chemistry, a purification mechanism (spin-column or magnetic bead) and run-tracking software on a common instrument architecture, with the choice between formats driven by throughput needs and sample type.
- Spin-column automation:
- Robotic centrifugal or vacuum systems automate the wash-and-elute cycle of a silica-membrane spin column, replicating the manual kit workflow without hands-on pipetting.
- Well suited to lower-throughput, single-sample or small-batch processing where spin-column kit chemistry is already validated and familiar.
- Magnetic-bead purification:
- A magnetic probe head moves between wells to capture bead-bound nucleic acid during wash steps, then releases it into elution buffer — a mechanism that scales more readily to 96- or 384-well parallel processing than spin columns.
- The dominant format for high-throughput molecular-diagnostics and genomics labs processing large daily sample volumes.
- Liquid-biopsy sample-prep integration:
- Specialized upstream sample-handling systems address the low-input, high-sensitivity demands of circulating cell-free DNA/RNA extraction from plasma, a distinct challenge from higher-input tissue or blood extraction.
- Vendor collaborations increasingly pair a liquid-handling automation platform with a dedicated liquid-biopsy sample-prep system rather than building both in-house.
Sources 5 · 0 independent · 5 producer sites
Producers' own sites 5
- Qiagen producer checked 2025-10-29 · link not kept
- Promega producer checked 2026-08-09 · link not kept
- Thermo fisher producer checked 2026-08-06 · link not kept
- Roche producer checked 2026-06-01 · link not kept
- Hamilton company producer checked 2026-01-27 · link not kept